ITP
CNMD icon

Iron Triangle Partners’s CONMED CNMD Stock Holding History

Iron Triangle Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-260,000
Closed -$24.9M – 30
2022
Q2 		$24.9M Buy
260,000
+99,470
+62% +$11.9M 3.23% 15
2022
Q1 		$23.8M Buy
160,530
+10,753
+7% +$1.5M 2.84% 18
2021
Q4 		$21.2M Sell
149,777
-40,223
-21% -$5.7M 2.96% 19
2021
Q3 		$24.9M Sell
190,000
-27,204
-13% -$3.56M 3.57% 10
2021
Q2 		$29.9M Buy
217,204
+17,204
+9% +$2.36M 3.07% 19
2021
Q1 		$26.1M Buy
200,000
+51,683
+35% +$6.22M 3.32% 15
2020
Q4 		$16.6M Buy
+148,317
New +$14M 2.15% 21

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Iron Triangle Partners's CNMD Position: Q3 2022 in Review

Iron Triangle Partners sold out of CONMED (CNMD) in Q3 2022, closing a stake of 260,000 shares — an estimated $24.9M sold.

Iron Triangle Partners first reported a position in CNMD in Q4 2020 and held it in 7 quarters. The position peaked at $29.9M in Q2 2021. 250 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Iron Triangle Partners reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
  • Iron Triangle Partners sold 260,000 CONMED shares in Q3 2022, an estimated $24.9M.
  • Iron Triangle Partners first reported a position in CONMED in Q4 2020 and held it in 7 quarters.
  • Iron Triangle Partners's CONMED position peaked at $29.9M in Q2 2021.
  • 250 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Iron Triangle Partners's 13F filing for Q3 2022, filed 14 Nov 2022.